Aster Al Raffah Walk Again Oman sets a new benchmark in neuro-rehabilitation with advanced robotics and global expertise.
Oman: Aster Al Raffah Hospitals & Clinics has launched the Aster Al Raffah Walk Again Advanced Robotic Rehabilitation Centre in Al Ghubra, Muscat — Oman’s first private robotic rehab facility. Powered by Aster DM Healthcare, the centre marks a major leap in neuro-rehabilitation for Oman, the GCC, and Africa.
Inaugurated by H.E. Dr. Ahmed bin Salim Al-Mandhari, Undersecretary, Ministry of Health, the facility integrates global innovation with local care. Spread across three floors, it treats stroke, spinal cord injuries, cerebral palsy, multiple sclerosis, traumatic brain injuries, and more — for both children and adults.
The centre offers cutting-edge technologies like the Cyberdyne HAL exoskeleton that uses muscle bio-signals to aid movement; Recoverix Pro, a brain-computer interface for stroke and MS rehab; Vibramoov for gait therapy; Luna EMG and Meissa OT for neuro and upper-limb rehab. Treatments like Deep Brain Stimulation and Vagus Nerve Stimulation further enhance recovery.
Led by Dr. Ali Al Balushi and a multidisciplinary team, the centre focuses on neuroplasticity—using US FDA-approved tech to restore brain function after injury. Supported by Walk Again India, it combines robotics with personalized care protocols for global-standard outcomes.
Dr. Azad Moopen, Founder Chairman, Aster DM Healthcare, stated, “This centre is part of our ‘Treat in Oman’ vision to reduce outbound medical travel and provide advanced care locally.” H.E. Dr. Al-Mandhari added, “This facility reflects Oman’s commitment to world-class innovation in healthcare.”
Ms. Alisha Moopen, Group CEO, called the launch “a defining moment in accessible, tech-driven care.” Dr. Sachin Kandhari, CEO, Walk Again India, emphasized the centre’s role in setting regional rehab standards.
Beyond treatment, the centre will drive medical research, host conferences, and elevate Oman as a regional healthcare hub — giving hope and mobility back to patients across borders.
